Remove 2025 Remove Court Rules Remove Litigating
article thumbnail

6 Paralegal Tips + An Invitation to Join Me

Paralegal Bootcamp

I’m holding a FREE 5-Day Paralegal Challenge that kicks off on March 24, 2025. But then an opening came up in the litigation department, and they decided to give it a try. Fast-forward twenty years, and they’re still loving their litigation paralegal career! So go read the rules, and then let’s talk.”

article thumbnail

The Czech Climate Case: Uncertainty after the Case’s Dismissal

ClimateChange-ClimateLaw

This blog post discusses the case and its implications for future climate litigation and policy in Czechia. However, the Court noted that nothing prevents Czechia from setting more ambitious climate goals. This shows that national legislation is fundamental.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Chinese Judicial Practice on Asymmetric Choice of Court Agreements in International Civil & Commercial Disputes

Conflict of Laws

This article gives a glimpse of how Chinese courts handle asymmetric choice of court agreements in international and commercial civil litigations. [4] Characterization Chinese courts have demonstrated mainly four different views in characterizing asymmetric choice of court agreements. 5] In Hang Seng Bank Ltd.

Court 45
article thumbnail

Praxis des Internationalen Privat- und Verfahrensrechts (IPRax) 5/2024: Abstracts

Conflict of Laws

Klink: Der Commercial Court nach dem Justizstandort-Stärkungsgesetz – ein Modellprojekt für grenzüberschreitende Gerichtsverfahren The Legal Venue Strengthening Act allows the German states to establish Commercial Courts at the higher regional courts as of 2025.

Divorce 59
article thumbnail

Oops!… [FDA] Did It Again: Another Orphan Drug Act Loss for FDA Based on Unambiguous Statutory Text; 11th Circuit Rules that the Scope of Orphan Drug Exclusivity is Determined by the Rare Disease or Condition Designated, and Not the Indication Approved

FDA Law Blog

As background, FDA approved Catalyst’s NDA for Firdapse (amifampridine) for the treatment of adult Lambert-Eaton myasthenic syndrome (LEMS) and, because the product had been designated an orphan drug, awarded Firdapse the statutory 7 years of orphan drug exclusivity expiring in November 2025. 6 to less than 17 years of age).

Statute 52
article thumbnail

The drop in straight grants is indeed not permanent — Part I

At the Lectern

Division Two reasoned that “burdening the excess insurers with prematurely litigating coverage issues before exhaustion upsets insurers settled expectations.” The Supreme Court directed the appellate court to issue an alternative writ. Rules of Court, rule 8.528(d); see In re Benoit (1973) 10 Cal.3d

article thumbnail

Retail Woes: A Running List of Fashion & Retail Bankruptcies

The Fashion Law

J.Crew has a $400 million exit term loan from Anchorage, GSO Capital Partners LP and others due 2027, and a $400 million asset-based lending credit facility due 2025 from Bank of America NA. Per MarketWatch, “J.Crew has swapped $1.6 billion in debt with Anchorage Capital Group LLC, which is now the majority owner of the company.

Finance 125